IL30448A - Protein metal chelate composition stabilized with saccharide,and preparation thereof - Google Patents

Protein metal chelate composition stabilized with saccharide,and preparation thereof

Info

Publication number
IL30448A
IL30448A IL30448A IL3044868A IL30448A IL 30448 A IL30448 A IL 30448A IL 30448 A IL30448 A IL 30448A IL 3044868 A IL3044868 A IL 3044868A IL 30448 A IL30448 A IL 30448A
Authority
IL
Israel
Prior art keywords
protein
saccharide
mixture according
sucrose
mixture
Prior art date
Application number
IL30448A
Other languages
English (en)
Other versions
IL30448A0 (en
Original Assignee
Diagnostic Data Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagnostic Data Inc filed Critical Diagnostic Data Inc
Publication of IL30448A0 publication Critical patent/IL30448A0/xx
Publication of IL30448A publication Critical patent/IL30448A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL30448A 1967-08-02 1968-07-26 Protein metal chelate composition stabilized with saccharide,and preparation thereof IL30448A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65797167A 1967-08-02 1967-08-02

Publications (2)

Publication Number Publication Date
IL30448A0 IL30448A0 (en) 1968-09-26
IL30448A true IL30448A (en) 1972-06-28

Family

ID=24639378

Family Applications (1)

Application Number Title Priority Date Filing Date
IL30448A IL30448A (en) 1967-08-02 1968-07-26 Protein metal chelate composition stabilized with saccharide,and preparation thereof

Country Status (12)

Country Link
JP (1) JPS5018056B1 (en:Method)
AT (1) AT304764B (en:Method)
BE (1) BE718887A (en:Method)
CH (1) CH611316A5 (en:Method)
DE (1) DE1792196C3 (en:Method)
DK (1) DK131273B (en:Method)
ES (1) ES356828A1 (en:Method)
FR (1) FR8127M (en:Method)
GB (1) GB1230127A (en:Method)
IL (1) IL30448A (en:Method)
NL (1) NL163720C (en:Method)
SE (1) SE375009B (en:Method)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5920647B2 (ja) * 1976-10-01 1984-05-15 武田薬品工業株式会社 注射剤
DE3176491D1 (en) * 1980-03-05 1987-11-26 Miles Lab Pasteurized therapeutically active protein compositions
JPS57140724A (en) * 1981-02-25 1982-08-31 Green Cross Corp:The Heat-treatment of aqueous solution containing cold insoluble globulin
JPS59157017A (ja) * 1983-02-25 1984-09-06 Green Cross Corp:The 静脈投与用γ−グロブリン製剤
US5055259A (en) * 1988-07-29 1991-10-08 Sanraku Incorporated Bloodless blood typing training kit
IL149778A0 (en) * 1999-11-22 2002-11-10 Universal Preservation Technologies Inc Preservation of sensitive biological material
US6872357B1 (en) 2000-11-22 2005-03-29 Quadrant Drug Delivery Limited Formulation of preservation mixtures containing sensitive biologicals to be stabilized for ambient temperature storage by drying

Also Published As

Publication number Publication date
JPS5018056B1 (en:Method) 1975-06-26
BE718887A (en:Method) 1969-01-31
NL6811058A (en:Method) 1969-02-04
AT304764B (de) 1973-01-25
NL163720B (nl) 1980-05-16
ES356828A1 (es) 1970-02-16
DE1792196A1 (de) 1972-05-18
SE375009B (en:Method) 1975-04-07
IL30448A0 (en) 1968-09-26
DK131273B (da) 1975-06-23
DE1792196B2 (de) 1980-08-14
GB1230127A (en:Method) 1971-04-28
CH611316A5 (en) 1979-05-31
DK131273C (en:Method) 1975-11-24
DE1792196C3 (de) 1981-04-02
NL163720C (nl) 1980-10-15
FR8127M (en:Method) 1970-08-10

Similar Documents

Publication Publication Date Title
US4165370A (en) Injectable gamma globulin
CA1327161C (en) Lyophilized pharmaceutical composition of neocarzinostatin derivative
CA1113861A (en) Stabilizer for polysaccharides
US4124576A (en) Method of producing intravenously injectable gamma globulin
CA1165236A (en) Method for producing gamma-globulin for use in intravenous administration and method for producing a pharmaceutical preparation thereof
US4724210A (en) Method for purification of influenza virus
US3637640A (en) Orgotein stabilized with saccharide process and products
US3929994A (en) Anti-inflammatory glycoprotein compositions and method of use
CA1223207A (en) Gamma interferon composition
JPH01502434A (ja) 新規インシュリン誘導体
US3855197A (en) Glycoproteins extracted from microorganisms
US2834712A (en) Urinary estrogen compositions and methods for preparing them
EP0232405A1 (en) GLUCANE SOLUBLE PHOSPHORYLE.
EP0035429A1 (fr) Complexe vaccinal contenant un antigène spécifique et vaccin le contenant
US4412946A (en) Immunostimulating glycoproteins
DK153948B (da) Analogifremgangsmaade til fremstilling af vandoploeselige associationsprodukter af (+)-katekin med en aminosyre og eventuelt tillige en anden syre
JPS63192724A (ja) ｒ−グロブリンの液状製剤
IL30448A (en) Protein metal chelate composition stabilized with saccharide,and preparation thereof
JPS6123167B2 (en:Method)
EP0017322B1 (en) Stabilization of capsular polysaccharides
EP0071515B1 (fr) Procédé d'obtention de polyosides capsulaires, polyosides capsulaires ainsi obtenus et leur application à la préparation de vaccins
US3987164A (en) Method for prevention of pseudomonas aeruginosa infections
JPS6016406B2 (ja) 静脈内に投与可能なガンマ・グロブリンの製造法ならびにそれにより調製したガンマ・グロブリン
IE51589B1 (en) Glycoproteins
JPH07157431A (ja) 安定なプロスタグランジンｅ製剤